Form 8-K - Current report:
SEC Accession No. 0001104659-24-072800
Filing Date
2024-06-18
Accepted
2024-06-18 16:05:49
Documents
14
Period of Report
2024-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417454d1_8k.htm   iXBRL 8-K 41205
2 EXHIBIT 10.1 tm2417454d1_ex10-1.htm EX-10.1 198187
  Complete submission text file 0001104659-24-072800.txt   449924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ntra-20240612.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntra-20240612_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntra-20240612_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2417454d1_8k_htm.xml XML 3684
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37478 | Film No.: 241051713
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)